English  |  正體中文  |  简体中文  |  Items with full text/Total items : 17938/22957 (78%)
Visitors : 7412472      Online Users : 189
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version
    Please use this identifier to cite or link to this item: https://ir.csmu.edu.tw:8080/ir/handle/310902500/15616


    Title: The Incidence of Gastric Adenocarcinoma among Patients with Gastric Intestinal Metaplasia A Long-term Cohort Study
    Authors: Lee, T.Y.
    Wang, R.C.
    Lee, Y.C.
    Lin, J.T.ij, Ho, H.J.
    Hsieh, M.C.
    Wu, C.-Y.
    Contributors: 醫學研究所
    Keywords: gastric cancer;precancerous;premalignant;surveillance
    Date: 2016-08-01
    Issue Date: 2016-08-04T03:57:12Z (UTC)
    Publisher: Lippincott Williams and Wilkins
    ISSN: 01920790
    Abstract: Background and Aims: Gastric intestinal metaplasia (IM) has been known as a premalignant condition, but estimates of its cancer risk vary widely. We aimed to analyze cancer risk of gastric IM by a long-term cohort study. Methods: We conducted a hospital-based study that included all patients with gastric IM between 1992 and 2010, and the development of gastric adenocarcinoma was evaluated until July 2011. Patients developing gastric cancer r180 days after the index diagnosis of IM were excluded. The incidence rate, the cumulative incidence, and the standardized incidence ratio (SIR) of gastric cancer were determined, and hazard ratios (HRs) of risk factors were calculated. Results: We identified 7059 patients with a median follow-up durationof 5.1 years, and 81 patients developed gastric adenocarcinoma duringthe study period. The 5-, 10-, and 15-year cumulative incidences of gastric cancer were 0.9% [95% confidence interval (CI), 0.6-1.1), 2.0% (95% CI, 1.5-2.6), and 3.0% (95% CI, 2.0-4.0), respectively. On multivariate analysis, older age (eg, 75 y and above; HR=7.4; 95% CI, 2.8-19.6), low-grade dysplasia (HR=4.0; 95% CI, 2.1-7.9), and high-grade dysplasia (HR=18.8; 95% CI, 9.0-39.5) were independent risk factors. As compared with the risk in the general population, the SIR of gastric cancer among patients with gastric IMwas 2.5 (95%CI, 2.0-3.1). However, the SIR was only 2.0 (95% CI, 1.5-2.6) in the nondysplasia subgroup, but was up to 35.2 (95% CI, 15.2-69.4) in the high-grade dysplasia subgroup. Conclusions: Gastric IM is an important risk factor for gastric cancer, but surveillance should be arranged only for those at an especially high risk. © Copyright 2016 Wolters Kluwer Health, Inc. All rights reserved.
    URI: https://ir.csmu.edu.tw:8080/ir/handle/310902500/15616
    http://dx.doi.org/10.1097/MCG.0000000000000406
    Relation: Journal of Clinical Gastroenterology Volume 50, Issue 7, 1 August 2016, Pages 532-537
    Appears in Collections:[醫學研究所] 期刊論文

    Files in This Item:

    File Description SizeFormat
    index.html0KbHTML315View/Open


    SFX Query

    All items in CSMUIR are protected by copyright, with all rights reserved.


    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback